New technology may help stop surgical implant infections
DeBogy Molecular, a biotech startup, claims its new technology can transform the surface implant surfaces so that bacteria doesn't grow and causes infections during procedures like hip and knee replacements.
Infections are often responsible for repeat surgery to correct problems with hip and knee implants. A biotech startup claims it now has a solution: a way to modify the surface of implants to repel bacteria.
DeBogy Molecular is a biotech company that has developed antimicrobial surface modification technology. This technology kills bacteria that can grow outside surgical implants and causes infections. This technology was able to eliminate what is known as bacterial Biofilm, which is a layer of microorganisms on the surgical implant's surface. It was tested in lab experiments with mice.
Also look at: SRL Home Collection Services
Wayne Gattinella CEO of DeBogy Molecular stated that the promise of a disruptive technology that can permanently protect an implantable device's surface from dangerous bacterial biofilm is transformative. He made the statement after announcing preliminary laboratory test results.
Gattinella stated that DeBogy technology "can save lives and drastically improve the quality life for millions of people, both young and old."
Comments
Post a Comment